Mohammed Abu-Rumaileh

Glucagon-like peptide-1 receptor agonist (GLP-1RAs) and more recently Twin-Cretins (GLP+GIP) are frequently used for patients with diabetes and associated obesity. In part their use is increasing based on the recommendation by the ADA and the EASD due to associated comorbidities…

The prevalence of obesity and metabolic consequences such as nonalcoholic fatty liver diseases (NAFLD) have considerably increased over the last several years, with NAFLD being the most common cause of chronic liver disease in the Western world…